vimarsana.com

Page 4 - பூமா உயிரி தொழில்நுட்பவியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Search jobs Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) LOS ANGELES (BUSINESS WIRE) Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on March 4, 2021 the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering an aggregate of 3,500 shares of Puma common stock to one new non-executive employee. The award was granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The restricted stock unit award vests over a three-year period, with one-third of the shares underlying each award vesting on the first anniversary of the award’s vesting commencement date, March 1, 2021, and one-sixth of the shares underlying each award vesting on each six-month anniversary of the vesting commencement date therea

CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration

Press release content from Business Wire. The AP news staff was not involved in its creation. CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration February 25, 2021 GMT BEIJING & CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 25, 2021 CANbridge Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing drug candidates in China and North Asia, and Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, have agreed to terminate their 2018 license agreement, in which Puma granted CANbridge exclusive rights to develop and commercialize NERLYNX® (neratinib) in Greater China, and to settle their arbitration related to the license agreement.

Conservative Power Couple Lead the War Against Disinformation

Conservative Power Couple Wage Legal War on Stolen-Election Myth Bloomberg 2/26/2021 Erik Larson (Bloomberg) A pair of self-described conservative lawyers are leading the fight to shut down the U.S. election conspiracy theory, pitting themselves against some of the loudest voices on the right. Tom Clare and Libby Locke, a married couple who run their own boutique firm, represent Dominion Voting Systems Inc. in lawsuits against Rudy Giuliani, Sidney Powell and MyPillow CEO Mike Lindell seeking a total of $3.9 billion for falsely claiming its voting machines were used to steal the 2020 election. Their battle is at the heart of an effort to stop a continuing stream of disinformation from Donald Trump’s supporters and they haven’t ruled out suing Trump himself.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (AFIB) - The Daily Biotech Pulse: Adcom Test Awaits J&J s COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (AFIB) - The Daily Biotech Pulse: Adcom Test Awaits J&J s COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.